Results 11 to 20 of about 73,895 (226)

Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda [PDF]

open access: gold, 2008
BACKGROUND: Poor adherence to highly active antiretroviral therapy (HAART) may result in treatment failure and death. Most reports of the effect of adherence to HAART on mortality come from studies where special efforts are made to provide HAART under ...
Andrew Abaasa   +6 more
openalex   +5 more sources

The Impact of HAART on the Respiratory Complications of HIV Infection: Longitudinal Trends in the MACS and WIHS Cohorts [PDF]

open access: yes, 2013
Objective: To review the incidence of respiratory conditions and their effect on mortality in HIV-infected and uninfected individuals prior to and during the era of highly active antiretroviral therapy (HAART).
A Johannessen   +63 more
core   +13 more sources

Subgingival Bacterial Microbiota Profile of People Living With HIV-1 Under HAART: A Systematic Review. [PDF]

open access: yesSpec Care Dentist
ABSTRACT Objective This systematic review aimed to assess the available literature on the subgingival bacterial microbiota profiles of PLHIV undergoing HAART. Materials and Methods This research was conducted in accordance with the PRISMA guidelines.
de Macedo TP   +6 more
europepmc   +2 more sources

Prevalence of Chronic Kidney Disease and Associated Factors Among Adult HIV/AIDS Patients on HAART in Hiwot Fana Comprehensive Specialized Hospital, Eastern Ethiopia: A Cross-Sectional Study. [PDF]

open access: yesHealth Sci Rep
ABSTRACT Background and Aims Chronic kidney disease related to human immunodeficiency virus infection has become a significant concern in sub‐Saharan Africa, primarily due to the high prevalence of the virus, along with delays in diagnosis and the initiation of highly active antiretroviral therapy.
Diba G, Abdu A, Solomon ET, Kucha W.
europepmc   +2 more sources

Gastric Kaposi Sarcoma With Distinct "Lobster-Like" Endoscopic Lesions in a Human Immunodeficiency Virus-Positive Patient. [PDF]

open access: yesDEN Open
ABSTRACT Kaposi Sarcoma (KS) is a rare vascular tumor linked to Human Herpesvirus‐8 (HHV‐8) infection, most often affecting immunocompromised patients with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS). Gastrointestinal KS (GI‐KS) is frequently underdiagnosed, particularly in resource‐limited settings, and may present with ...
Safizadeh Shabestari SA   +2 more
europepmc   +2 more sources

Human immunodeficiency virus rebound after suppression to < 400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression [PDF]

open access: yes, 2002
This study evaluated 1433 human immunodeficiency virus (HIV)-infected patients starting highly active antiretroviral therapy (HAART), 409 (28%) of whom had prior nucleoside experience and achieved an HIV load of
Bickel, M   +11 more
core   +1 more source

Low-Level HIV-I Replication and the Dynamics of the Resting CD4(+) T Cell Reservoir for HIV-I in the Setting of HAART [PDF]

open access: yes, 2008
In the setting of highly active antiretroviral therapy (HAART), plasma levels of human immunodeficiency type-I (HIV-I) rapidly decay to below the limit of detection of standard clinical assays.
Sedaghat, Ahmad R.   +2 more
core   +1 more source

Adherence to highly active antiretroviral treatment in HIV-infected Rwandan women. [PDF]

open access: yesPLoS ONE, 2011
Scale-up of highly active antiretroviral treatment therapy (HAART) programs in Rwanda has been highly successful but data on adherence is limited. We examined HAART adherence in a large cohort of HIV+ Rwandan women.The Rwanda Women's Interassociation ...
Stephenson Musiime   +10 more
doaj   +1 more source

Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection [PDF]

open access: yes, 2003
Liver-related mortality is an increasing problem in human immunodeficiency virus (HIV)/hepatitis B virus (HBV)-coinfected patients receiving highly active antiretroviral therapy (HAART).
Bertoletti, A   +4 more
core   +1 more source

Virological treatment outcome under HAART : does sex matter? [PDF]

open access: yes, 2008
Background: In Germany, 17% of 59,000 persons living with HIV/AIDS are female. Accordingly, the research focus in clinical studies as well as in cohort analyses has been almost exclusively on HIV-positive men. As a consequence, there is an urgent need to
Haberl, Annette Elisabeth   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy